In the current study, we concentrated on the signaling pathways where PARM1 was involved, and we showed that PARM1 could induce PASMC proliferation via an AKT/FOXO3A/PCNA-dependent signaling pathway in PAH. Here, PARM1 is linked to pulmonary arterial hypertension.